The hypothesis that lipid and energy metabolisms are impaired in MF is consistent with a recent report indicating that the JAK2 mutation alters lipid and glucose metabolism in animal models of myeloproliferative neoplasms. The gene discussed is JAK2; the disease is myeloproliferative disorder.